University of British Columbia to Perform Clinical Study on the Cardiovascular and Cognitive Health Effects of Lexaria’s TurboCBDTM. Sep 1, 2017
Successful CANTOS Inflammation Trial Supports Rationale for Resverlogix’ Ongoing BETonMACE Trial Aug 29, 2017
Lexaria Announces Attendance at Two Cannabis Investment Conferences, and Issues Shares for Debt Aug 29, 2017
Resverlogix Announces Extension of Maturity Date of Loan and Expression of Interest Regarding Strategic Transaction Aug 28, 2017
Future Farm to Double Size and Ramp Up Baltimore Vertical Farming Project With Second Location Aug 27, 2017
Volition Signs Agreement with the Institute of Laboratory Medicine of the Technical University of Munich, Germany, to assist in securing large trials in a range of cancers Aug 22, 2017 Life Science
RedHill Biopharma Announces U.S. Commercialization Agreement for FDA-Approved GI Product Esomeprazole Strontium Delayed-Release Capsules Aug 18, 2017 Life Science
Future Farm Announces $500,000 Line of Credit and Shareholder Conference Call Aug 16, 2017 Life Science
Naturally Splendid Enterprises’ CEO Dave Eto Discusses the Company and the Acquisition of 100% of Prosnack Natural Foods – Video of Interview on InvestmentPitch.com Aug 14, 2017 Life Science
